Glipizide
NDC 60760-794, Glipizide, tablet, extended release, from St. Mary's Medical Park Pharmacy.
- Product NDC
- 60760-794
- Status
- Listed
- Labeler
- St. Mary's Medical Park Pharmacy
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206928
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60760-794 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLIPIZIDE5 mg/1
Pharmacologic classes
Sulfonylurea Compounds [CS]; Sulfonylurea [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60760-794-30 | 60760079430 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (60760-794-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1b2ef6e2-5e7c-761e-e063-6294a90addd0
Use it
Look up 60760-794 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60760-794 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60760-794. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.